Search CDMOs

• CMC Analytical Development
• API Synthesis & Manufacturing
• Biologics Development & Manufacturing

Lonza is the world's leading CDMO, founded in Switzerland in 1897, serving the healthcare industry with integrated offerings for contract development and manufacturing of therapies across multiple modalities.

• CMC Analytical Development
• API Synthesis & Manufacturing
• CMC Regulatory Submission Support

ARSI Canada is a specialized CRO offering custom synthesis, API scale-up, analytical method development, and drug development services with over 50 years of combined experience and a GMP manufacturing facility in Bangladesh.

• ADC (Antibody-Drug Conjugate) Manufacturing
• ADC Payload & Linker Synthesis
• CMC Analytical Development

Fully integrated biologics and bioconjugates CDMO+CRO offering drug design, development, and GMP manufacturing for antibodies, ADCs, AOCs, RDCs, and vaccines from discovery through commercial scale.

• CMC Analytical Development
• Cartridge Filling
• CMC Regulatory Submission Support

US-based aseptic fill-finish CDMO specializing in parenteral biologics, peptides, and small molecules from development through commercial supply, with formulation, analytical, stability testing, and vial/syringe/cartridge filling capabilities.

• CMC Analytical Development
• API Synthesis & Manufacturing
• CMC Regulatory Submission Support

CMC Pharma provides integrated formulation development, analytical testing, stability studies, and cGMP manufacturing oversight for small molecule drug programs from preclinical through post-approval, with hands-on regulatory expertise and CMO management built in.

• CMC Analytical Development
• Controlled Substance Manufacturing
• Formulation Development

Independent, family-owned CDMO specializing in oral solids, semi-solids, and controlled-substance manufacturing with 475,000 sq ft cGMP facility in Bristol, TN; over 80 products commercialized.

• CMC Analytical Development
• API Synthesis & Manufacturing
• CMC Regulatory Submission Support

India's largest CDMO with 15+ state-of-the-art facilities and 30% domestic market share, manufacturing 4,100+ formulations across tablets, capsules, injectables, APIs, and specialty dosage forms under WHO-GMP, USFDA, EU-GMP, and TGA compliance.

• CMC Analytical Development
• CMC Regulatory Submission Support
• Sterile Fill-Finish & Aseptic Manufacturing

Ascendia is a specialty CDMO providing formulation development, analytical services, and GMP manufacturing for small molecules and biologics from pre-formulation through commercialization, with proprietary nanotechnologies including LipidSol, EmulSol, AmorSol, and NanoSol.

• ADC (Antibody-Drug Conjugate) Manufacturing
• CMC Analytical Development
• API Synthesis & Manufacturing

Ardena is an integrated CDMO and bioanalytical CRO specializing in advanced drug product development, nanomedicine, and bioanalysis for complex molecules including poorly soluble compounds, highly potent APIs, and controlled substances.

• CMC Analytical Development
• CMC Regulatory Submission Support
• Formulation Development

Glatt Pharmaceutical Services is a CDMO specializing in complex oral solid dosage forms, multiparticulate systems (pellets, micropellets, granules), and advanced drug delivery solutions including controlled release, solubility enhancement, and taste masking from early development through commercial manufacturing.

• CMC Analytical Development
• Cell-Line Development
• CMC Regulatory Submission Support

European CDMO specializing in microbial and precision fermentation up to 40,000 L across two integrated sites (Pamplona, Spain and Basel, Switzerland), with core strengths in E. coli expression, animal health biologics, probiotics, and complex CMC programs requiring scale-up discipline and impurity control.

• CMC Analytical Development
• Cell-Line Development
• Cell Therapy Manufacturing

Cell therapy CDMO offering end-to-end development, GMP manufacturing, and regulatory support from preclinical through commercial scale, with specialized expertise in T cells, NK cells, MSCs, iPSCs, and other cell modalities.

• CMC Analytical Development
• CMC Regulatory Submission Support
• Sterile Fill-Finish & Aseptic Manufacturing

Germany-based CDMO specializing in nanoparticle formulation, process development, GMP manufacturing, and aseptic fill-finish for nanomedicines and advanced drug delivery products.

• CMC Analytical Development
• API Synthesis & Manufacturing
• Biologics Development & Manufacturing

Italian CDMO with 50 years of experience offering custom development and manufacturing of active pharmaceutical ingredients, finished dosage forms, and biotech solutions including monoclonal antibodies, with FDA and AIFA approvals.

• CMC Analytical Development
• CMC Regulatory Submission Support
• Sterile Fill-Finish & Aseptic Manufacturing

Hongene is a vertically-integrated CDMO offering end-to-end oligonucleotide and mRNA manufacturing from raw materials to GMP drug product, with nearly 30 years of RNA-focused expertise and tonne-scale production capacity.

• CMC Analytical Development
• CMC Regulatory Submission Support
• mRNA Manufacturing

Global CDMO leader in nucleic acid manufacturing and analysis (mRNA, ASO, siRNA, guide RNA, oligonucleotides) with nearly three decades of expertise, GMP certification since 2007, and support for 9 commercial programs across all clinical phases.

• CMC Analytical Development
• API Synthesis & Manufacturing
• Sterile Fill-Finish & Aseptic Manufacturing

Gland Pharma is a vertically integrated CDMO offering sterile injectable manufacturing across vials, lyophilized, prefilled syringes, and ophthalmic formats, with four cGMP-compliant formulation facilities and four API manufacturing units, supported by R&D capabilities in formulation, analytical, and process development.

• CMC Analytical Development
• CMC Regulatory Submission Support
• Formulation Development

Global CDMO specializing in commercial-scale spray drying, amorphous solid dispersions, microencapsulation, and continuous granulation with 400,000 sq ft of GMP manufacturing across US and UK facilities.